HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 72 filers reported holding HOOKIPA PHARMA INC in Q4 2021. The put-call ratio across all filers is 1.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,829 | -10.3% | 14,333 | +28.1% | 0.00% | – |
Q2 2023 | $9,845 | +61431.2% | 11,187 | -50.1% | 0.00% | -100.0% |
Q1 2023 | $16 | -30.4% | 22,400 | -21.6% | 0.00% | 0.0% |
Q4 2022 | $23 | – | 28,560 | +150215.8% | 0.00% | – |
Q3 2022 | $0 | – | 19 | -82.7% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 110 | -97.9% | 0.00% | – |
Q1 2022 | $13,000 | -71.1% | 5,360 | -72.3% | 0.00% | -100.0% |
Q4 2021 | $45,000 | +181.2% | 19,327 | +627.9% | 0.00% | – |
Q3 2021 | $16,000 | -87.6% | 2,655 | -81.2% | 0.00% | -100.0% |
Q2 2021 | $129,000 | +821.4% | 14,092 | +1223.2% | 0.00% | – |
Q1 2021 | $14,000 | -67.4% | 1,065 | -72.3% | 0.00% | -100.0% |
Q4 2020 | $43,000 | -63.6% | 3,851 | -69.1% | 0.00% | 0.0% |
Q3 2020 | $118,000 | +25.5% | 12,455 | +54.5% | 0.00% | -75.0% |
Q2 2020 | $94,000 | +840.0% | 8,061 | +582.6% | 0.00% | +300.0% |
Q1 2020 | $10,000 | +42.9% | 1,181 | +104.0% | 0.00% | 0.0% |
Q4 2019 | $7,000 | +133.3% | 579 | +44.4% | 0.00% | – |
Q3 2019 | $3,000 | -92.5% | 401 | -93.3% | 0.00% | -100.0% |
Q2 2019 | $40,000 | – | 6,011 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 1,842,902 | $17,452,000 | 0.32% |
Samsara BioCapital, LLC | 116,602 | $1,104,000 | 0.31% |
Artal Group S.A. | 599,616 | $5,678,000 | 0.14% |
HHLR ADVISORS, LTD. | 943,254 | $8,933,000 | 0.07% |
DAFNA Capital Management LLC | 22,061 | $209,000 | 0.07% |
Baker Brothers Advisors | 700,481 | $6,634,000 | 0.03% |
ZACKS INVESTMENT MANAGEMENT | 72,064 | $682,000 | 0.01% |
HOWLAND CAPITAL MANAGEMENT LLC | 14,728 | $139,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,374 | $139,000 | 0.00% |
Squarepoint Ops LLC | 12,699 | $120,000 | 0.00% |